Can coexisting iron and B12/folate deficiencies produce a near-normal MCV with increased RDW and still impair oxygen delivery?

In hematology, the coexistence of iron deficiency and vitamin B12 or folate deficiency creates a complex clinical picture known as dimorphic anemia. While these deficiencies have opposing effects on red blood cell size, their combined impact consistently impairs systemic oxygen transport.

Hematologic mechanisms and MCV normalization

The "near-normal" mean corpuscular volume (MCV) observed in mixed deficiencies is a result of physiological neutralization rather than a lack of pathology.

• Opposing Morphologies: Iron deficiency typically leads to microcytosis (small red blood cells) due to impaired hemoglobin synthesis. Conversely, B12 and folate deficiencies cause macrocytosis (large red blood cells) by disrupting DNA synthesis during erythropoiesis.
• The Masking Effect: When these conditions coexist, the average cell size (MCV) often falls within the standard reference range (80–100 fL). Studies indicate that a normal MCV is present in approximately 56% to 65% of dimorphic anemia cases, which can lead to the underdiagnosis of underlying nutritional deficits if MCV is used as the sole screening tool.
• RDW as a Diagnostic Marker: While the MCV remains stable, the Red Cell Distribution Width (RDW) significantly increases. This reflects high anisocytosis—the presence of two distinct populations of red blood cells (microcytic and macrocytic). An elevated RDW (typically >15%) combined with a normal MCV is a classic diagnostic signal for a mixed nutritional deficiency.

Impact on oxygen delivery and clinical symptoms

A "normal" MCV does not equate to normal blood function. The mixed pattern fundamentally reduces the blood's oxygen-carrying capacity through several mechanisms:

• Reduced Hemoglobin Mass: Despite the average size of the cells, the total concentration of hemoglobin and the total red cell mass are significantly diminished. This directly lowers the oxygen content of arterial blood.
• Systemic Oxygen Debt: Reduced hemoglobin levels impair tissue oxygen delivery ($DO_2$), leading to lower tissue oxygen saturation ($StO_2$) and a decline in $VO_2$ max (peak oxygen uptake).
• Clinical Manifestations: The body compensates for reduced oxygen delivery by increasing cardiac output (heart rate and stroke volume). This physiological strain manifests as persistent fatigue and shortness of breath (exertional dyspnea), as the hematologic system fails to meet the metabolic demands of tissues during activity.

Bottom line

When iron and B12/folate deficiencies coexist, the MCV often appears misleadingly normal because small and large cells average out; however, a high RDW reveals the underlying "mixed" pathology. This condition remains a significant clinical concern as it reduces total hemoglobin, impairs oxygen delivery to tissues, and causes progressive fatigue and shortness of breath.